N/A
N=39
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer
Cancer
Bottom Line
View on ClinicalTrials.gov: NCT00253708 ↗Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Aug 2017
Primary outcome: Primary: Pain — 0; 0; 0; 0 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- management of therapy complications (Procedure); massage therapy (Procedure); pain therapy (Procedure); psychosocial assessment and care (Procedure); quality-of-life assessment (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Beth Israel Deaconess Medical Center
- Primary completion
- Jan 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain |
0; 0; 0; 0; 0; -2 | — |
| PRIMARY Anxiety |
0; 0; 0; 0; 0; 0 | — |
| PRIMARY Alertness |
0; 0; 1; 0; 0; 0 | — |
| SECONDARY Quality of Life: Physical Well-being |
1; -0.5; 0; 0; 0; 0 | — |
| SECONDARY Quality of Life: Psychological Well-being |
1.125; 0.25; 0; -0.125; 0.25; 0.75 | — |
| SECONDARY Quality of Life: McGill Total |
0.45; 0; 0; 0; -0.18; 0 | — |
| SECONDARY Sleep |
-3.5; 0; -0.5; -4; 0; 0 | — |
Summary
RATIONALE: Massage therapy may help relieve symptoms associated with cancer. It is not yet known which type of massage therapy is more effective in treating the symptoms of patients with cancer.
PURPOSE: This randomized clinical trial is studying different types of massage therapy to compare how well they work in treating the symptoms of patients with locally advanced or metastatic cancer.
Eligibility Criteria
Inclusion criteria
- Solid cancer with evidence of metastases
- Receiving treatment at Beth Israel Deaconess Medical Center (BIDMC)
- Must reside ≤ 25 miles from BIDMC
Exclusion criteria
- Patient to sick to be interviewed
- Absence of severe symptoms
- Participating in another trial
- Language barrier
- MD does not provide permission
- Expired prior to consent process
Data sourced from ClinicalTrials.gov (NCT00253708). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.